NuCana plc
Phosphoramidate nucleoside derivatives as anticancer agents

Last updated:

Abstract:

This invention relates to derivatives of cladribine of Formula (I). The compounds are phosphoramidate derivatives in which the phosphoramidate moiety is situated on the 3'-hydroxyl group of cladribine. The invention also relates to pharmaceutical formulations of the cladribine derivatives and their use in methods of treatment. The compounds are useful in the treatment of cancer. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

31 May 2017

Issue date:

2 Feb 2021